Chitinase 3-like 1 gene (T/C) polymorphism and serum YKL-40 levels in patients with hepatocellular carcinoma

The chitinase 3-like 1 (CHI3L1) gene encodes the YKL-40 protein. Serum YKL-40 levels are controlled by polymorphisms in the CHI3L1 gene. We aimed to examine the association of the rs880633 (T/C) polymorphism in the CHI3L1 gene with serum YKL-40 levels and to evaluate the role of this polymorphism as...

Full description

Saved in:
Bibliographic Details
Published inMeta Gene Vol. 24; p. 100686
Main Authors Saleh, Amany A., Alhanafy, Alshimaa M., Elbahr, Osama, El-Hefnawy, Sally M.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The chitinase 3-like 1 (CHI3L1) gene encodes the YKL-40 protein. Serum YKL-40 levels are controlled by polymorphisms in the CHI3L1 gene. We aimed to examine the association of the rs880633 (T/C) polymorphism in the CHI3L1 gene with serum YKL-40 levels and to evaluate the role of this polymorphism as a risk factor for HCC and its effect on patient survival. A total of 225 subjects were categorized into two groups: group I included 120 patients with HCC, and group II involved 105 age and gender-matched healthy volunteers. Genotypes of the rs880633 (T/C) polymorphism in the CHI3L1 gene were analyzed using an allele discrimination assay with real-time PCR, and serum YKL-40 levels were determined using an ELISA technique. A significant difference in the genotype frequency of the T/C polymorphism in the CHI3L1 gene was observed between the two groups, with an increase in the frequency of the CC genotype observed among patients with HCC. Regarding the allelic distribution, the C allele was significantly predominant in patients, with HCC presenting with an increased HCC risk compared to the T allele. Subjects with the CC genotype had the highest serum YKL-40 levels, followed by those with the TC genotype, while subjects with the TT genotype had the lowest serum YKL-40 levels. An analysis of the overall survival of HCC patients revealed that patients with both the CC and CT genotypes displayed a significantly shorter survival rate than patients carrying the TT genotype. The rs880633 polymorphism in the CHI3L1 gene may be a risk element for HCC. Patients with the CC genotype displayed the highest serum YKL-40 levels, which were linked to poor prognosis. •SNP rs880633 at CHI3L1 gene may be a potential risk factor for HCC progression.•HCC patients carrying CC and TC genotypes have the highest serum CHI3L1 or YKL40 levels•HCC patients carrying CC genotype have bad prognosis and short survival•SNP rs880633 at CHI3L1 gene could predict the overall survival and disease outcome.
AbstractList The chitinase 3-like 1 (CHI3L1) gene encodes the YKL-40 protein. Serum YKL-40 levels are controlled by polymorphisms in the CHI3L1 gene. We aimed to examine the association of the rs880633 (T/C) polymorphism in the CHI3L1 gene with serum YKL-40 levels and to evaluate the role of this polymorphism as a risk factor for HCC and its effect on patient survival. A total of 225 subjects were categorized into two groups: group I included 120 patients with HCC, and group II involved 105 age and gender-matched healthy volunteers. Genotypes of the rs880633 (T/C) polymorphism in the CHI3L1 gene were analyzed using an allele discrimination assay with real-time PCR, and serum YKL-40 levels were determined using an ELISA technique. A significant difference in the genotype frequency of the T/C polymorphism in the CHI3L1 gene was observed between the two groups, with an increase in the frequency of the CC genotype observed among patients with HCC. Regarding the allelic distribution, the C allele was significantly predominant in patients, with HCC presenting with an increased HCC risk compared to the T allele. Subjects with the CC genotype had the highest serum YKL-40 levels, followed by those with the TC genotype, while subjects with the TT genotype had the lowest serum YKL-40 levels. An analysis of the overall survival of HCC patients revealed that patients with both the CC and CT genotypes displayed a significantly shorter survival rate than patients carrying the TT genotype. The rs880633 polymorphism in the CHI3L1 gene may be a risk element for HCC. Patients with the CC genotype displayed the highest serum YKL-40 levels, which were linked to poor prognosis. •SNP rs880633 at CHI3L1 gene may be a potential risk factor for HCC progression.•HCC patients carrying CC and TC genotypes have the highest serum CHI3L1 or YKL40 levels•HCC patients carrying CC genotype have bad prognosis and short survival•SNP rs880633 at CHI3L1 gene could predict the overall survival and disease outcome.
ArticleNumber 100686
Author Alhanafy, Alshimaa M.
El-Hefnawy, Sally M.
Saleh, Amany A.
Elbahr, Osama
Author_xml – sequence: 1
  givenname: Amany A.
  surname: Saleh
  fullname: Saleh, Amany A.
  email: amanybio@yahoo.com, amany.saleh@med.menofia.edu.eg
  organization: Medical Biochemistry & Molecular Biology, Egypt
– sequence: 2
  givenname: Alshimaa M.
  surname: Alhanafy
  fullname: Alhanafy, Alshimaa M.
  organization: Clinical Oncology & Nuclear Medicine Departments, Faculty of Medicine, Menoufia University, Egypt
– sequence: 3
  givenname: Osama
  surname: Elbahr
  fullname: Elbahr, Osama
  email: osama.elbahr@liver.menofia.edu.eg
  organization: Hepatology and Gastroenterology Department, National Liver Institute, Menoufia University, Egypt
– sequence: 4
  givenname: Sally M.
  orcidid: 0000-0003-3090-0141
  surname: El-Hefnawy
  fullname: El-Hefnawy, Sally M.
  email: doctor_sally@rocketmail.com
  organization: Medical Biochemistry & Molecular Biology, Egypt
BookMark eNp9kD9PwzAQxS1UJErpJ2DxCEPac5yYZmBAFf9EJZYyMFmucyYujhPZaVG_PQllYGK6u3d6T3q_czLyjUdCLhnMGDAx387qD_Q4SyEdFBALcULGacqyJM8ARn_2MzKNcQsALGVFzsSYuGVlO-tVRMoTZz-RMjqk0av1fHlN28Yd6ia0lY01Vb6kEcOupu8vqyQD6nCPLlLraas6i76L9Mt2Fa2wvxuNzu2cClSroK1vanVBTo1yEae_c0LeHu7Xy6dk9fr4vLxbJZoD75JNBgJMpstUQJ6XYpEVpSqM4jdojNiY_mm4MoUxUCqRqiznDAvOc5UahE3OJ4Qfc3VoYgxoZBtsrcJBMpADM7mVP8zkwEwemfWu26Or74R7i0FG3ZfSWNqAupNlY__1fwN-PnfC
CitedBy_id crossref_primary_10_1002_iub_2444
crossref_primary_10_3390_ijms25126768
crossref_primary_10_3390_ijms23042361
crossref_primary_10_1111_jcmm_18012
Cites_doi 10.1016/S0014-4827(03)00069-7
10.1158/1535-7163.MCT-10-0868
10.1007/s11010-014-2277-y
10.1189/jlb.3VMR0415-142R
10.1371/journal.pone.0005469
10.1084/jem.20081271
10.1086/510438
10.1111/j.1440-1789.2011.01252.x
10.1016/j.rmed.2006.12.006
10.1074/jbc.M306792200
10.1159/000444855
10.1016/j.cyto.2010.12.018
10.1038/s41598-018-33239-8
10.3748/wjg.15.5249
10.1371/journal.pone.0024399
10.1245/s10434-010-0985-4
10.1016/j.clinbiochem.2010.07.017
10.1042/bj20020075
10.1007/s12026-013-8459-y
10.1038/srep35282
10.1200/JCO.2008.18.8367
10.1056/NEJMoa060570
10.1245/s10434-011-2026-3
10.7150/ijms.17754
10.1111/j.1478-3231.2011.02686.x
10.1038/onc.2009.292
10.1002/pros.20311
10.1097/00000421-198212000-00014
10.3889/oamjms.2015.111
10.3322/caac.21208
10.1158/1078-0432.CCR-04-1765
ContentType Journal Article
Copyright 2020 Elsevier B.V.
Copyright_xml – notice: 2020 Elsevier B.V.
DBID AAYXX
CITATION
DOI 10.1016/j.mgene.2020.100686
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2214-5400
ExternalDocumentID 10_1016_j_mgene_2020_100686
S2214540020300414
GroupedDBID --M
0SF
4.4
457
5VS
6I.
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAXUO
ABMAC
ABUDA
ABYKQ
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
AEBSH
AEHWI
AEXQZ
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AIEXJ
AIKHN
AITUG
AJBFU
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AOIJS
AXJTR
BAWUL
BKOJK
DIK
EBS
EFJIC
EFLBG
EJD
FDB
FIRID
FYGXN
GX1
HYE
IXB
KOM
KQ8
M41
NCXOZ
OK1
ROL
RPM
SPCBC
SSU
SSZ
T5K
0R~
AAQFI
AAXKI
AAYXX
ADVLN
AKRWK
CITATION
ID FETCH-LOGICAL-c303t-b4060f4cd26055d6849da9fa37eff6bf60ff3af9ff0da62a4531e9335a2fe0b53
IEDL.DBID IXB
ISSN 2214-5400
IngestDate Thu Sep 12 17:02:07 EDT 2024
Fri Feb 23 02:49:23 EST 2024
IsPeerReviewed false
IsScholarly false
Keywords HCC
YKL-40
Chitinase 3-like 1
Polymorphism
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c303t-b4060f4cd26055d6849da9fa37eff6bf60ff3af9ff0da62a4531e9335a2fe0b53
ORCID 0000-0003-3090-0141
ParticipantIDs crossref_primary_10_1016_j_mgene_2020_100686
elsevier_sciencedirect_doi_10_1016_j_mgene_2020_100686
PublicationCentury 2000
PublicationDate June 2020
2020-06-00
PublicationDateYYYYMMDD 2020-06-01
PublicationDate_xml – month: 06
  year: 2020
  text: June 2020
PublicationDecade 2020
PublicationTitle Meta Gene
PublicationYear 2020
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Shao, Hamel, Petersen, Cao, Arenas, Bigelow, Bentley, Yan (bb0155) 2009; 28
Lee, Hartl, Lee, Koller, Matsuura, Da Silva, Sohn, Cohn, Homer, Kozhich, Humbles, Kearley, Coyle, Chupp, Reed, Flavell, Elias (bb0085) 2009; 206
Faibish, Francescone, Bentley, Yan, Shao (bb0040) 2011; 10
Di Rosa, Malaguarnera (bb0015) 2016; 83
Lee, Kang, Jee, Yoon (bb0090) 2010; 43
Zhao, Tang, Gao, Shi, Zhou, Guo, Zhang, Wang, Tang, Meng, Li, Wang, Ma, Lin, Xiao, Feng, Lin, Zhu, Xing, Sang, St. Clair, He (bb0165) 2007; 80
Kumagai, Mano, Yoshio, Shoji, Sugiyama, Korenaga, Ishida, Arai, Itokawa, Atsukawa, Hyogo, Chayama, Ohashi, Ito, Yoneda, Kawaguchi, Torimura, Nozaki, Watanabe, Mizokami, Kanto (bb0080) 2016; 6
Huang, Lin, Yeh, Chen, Chou, Yang, Liu (bb0055) 2017; 14
Pelloski, Mahajan, Maor, Chang, Woo, Gilbert, Colman, Yang, Ledoux, Blair, Passe, Jenkins, Aldape (bb0125) 2005; 11
Antonelli, Massimino, Morra, Garrè, Gardiman, Buttarelli, Arcella, Giangaspero (bb0005) 2012; 32
Johansen, Bojesen, Mylin, Frikke-Schmidt, Price, Nordestgaard (bb0070) 2009; 27
Erfan, Guzel, Alpsoy, Rifaioglu, Kaya, Kucukyalcın, Topcu, Kulac (bb0030) 2015; 400
Shaker (bb0150) 2016
Zhu, Chen, Tian, Su, Wang, Gai, Du, Ma (bb0175) 2012; 19
El-Zayadi, Badran, Barakat, Attia, Shawky, Mohamed, Selim, Saeid (bb0025) 2005; 11
Mohammadian, Mahdavifar, Mohammadian-Hafshejan, Salehiniya (bb0105) 2018; 5
Oken, Creech, Tormey, Horton, Davis, McFadden, Carbone (bb0115) 1982; 5
Brasso, Christensen, Johansen, Teisner, Garnero, Price, Iversen (bb0010) 2006; 66
Libreros, Garcia-Areas, Iragavarapu-Charyulu (bb0100) 2013; 57
Johansen (bb0065) 2006; 53
Edge, Compton (bb0020) 2010
Kruit, Grutters, Ruven, van Moorsel, van den Bosch (bb0075) 2007; 101
Zheng, Lu, Hu, Zhang, Zhang, Chen, Shen (bb0170) 2011; 54
Janevska, Chaloska-Ivanova, Janevski (bb0060) 2015; 3
Qiu, Wang, Jin, Liu, Liu, Ma, Mao, Ma, Zhao, Chen, Lin (bb0130) 2018; 8
Olaussen, Dunant, Fouret, Brambilla, André, Haddad, Taranchon, Filipits, Pirker, Popper, Stahel, Sabatier, Pignon, Tursz, Le Chevalier, Soria (bb0120) 2006; 355
Hector, Kormann, Mack, Latzin, Casaulta, Kieninger, Zhou, Yildirim, Bohla, Rieber, Kappler, Koller, Eber, Eickmeier, Zielen, Eickelberg, Griese, Mall, Hartl (bb0050) 2011; 6
Rehli, Niller, Ammon, Langmann, Schwarzfischer, Andreesen, Krause (bb0145) 2003; 278
Fontana, Litman, Dienstag, Bonkovsky, Su, Sterling, Lok, Group (bb0045) 2012; 32
Zhu, Wang, Chen, Ma, Zhang, Su, Tian, Gai (bb0180) 2012; 7
Libreros, Iragavarapu-Charyulu (bb0095) 2015; 98
Nishikawa, Millis (bb0110) 2003; 287
Rathcke, Holmkvist, Jørgensen, Borch-Johnsen, Hansen, Pedersen, Vestergaard (bb0135) 2009; 4
Eurich, Segawa, Toei-Shimizu, Mizoguchi (bb0035) 2009; 15
Siegel, Ma, Zou, Jemal (bb0160) 2014; 64
Recklies, White, Ling (bb0140) 2002; 365
Lee (10.1016/j.mgene.2020.100686_bb0085) 2009; 206
Antonelli (10.1016/j.mgene.2020.100686_bb0005) 2012; 32
Zhao (10.1016/j.mgene.2020.100686_bb0165) 2007; 80
Mohammadian (10.1016/j.mgene.2020.100686_bb0105) 2018; 5
Hector (10.1016/j.mgene.2020.100686_bb0050) 2011; 6
Lee (10.1016/j.mgene.2020.100686_bb0090) 2010; 43
Johansen (10.1016/j.mgene.2020.100686_bb0070) 2009; 27
Zhu (10.1016/j.mgene.2020.100686_bb0175) 2012; 19
Brasso (10.1016/j.mgene.2020.100686_bb0010) 2006; 66
Erfan (10.1016/j.mgene.2020.100686_bb0030) 2015; 400
Faibish (10.1016/j.mgene.2020.100686_bb0040) 2011; 10
Janevska (10.1016/j.mgene.2020.100686_bb0060) 2015; 3
Nishikawa (10.1016/j.mgene.2020.100686_bb0110) 2003; 287
Siegel (10.1016/j.mgene.2020.100686_bb0160) 2014; 64
Huang (10.1016/j.mgene.2020.100686_bb0055) 2017; 14
Rathcke (10.1016/j.mgene.2020.100686_bb0135) 2009; 4
El-Zayadi (10.1016/j.mgene.2020.100686_bb0025) 2005; 11
Rehli (10.1016/j.mgene.2020.100686_bb0145) 2003; 278
Kruit (10.1016/j.mgene.2020.100686_bb0075) 2007; 101
Qiu (10.1016/j.mgene.2020.100686_bb0130) 2018; 8
Olaussen (10.1016/j.mgene.2020.100686_bb0120) 2006; 355
Libreros (10.1016/j.mgene.2020.100686_bb0100) 2013; 57
Zhu (10.1016/j.mgene.2020.100686_bb0180) 2012; 7
Eurich (10.1016/j.mgene.2020.100686_bb0035) 2009; 15
Fontana (10.1016/j.mgene.2020.100686_bb0045) 2012; 32
Kumagai (10.1016/j.mgene.2020.100686_bb0080) 2016; 6
Libreros (10.1016/j.mgene.2020.100686_bb0095) 2015; 98
Shao (10.1016/j.mgene.2020.100686_bb0155) 2009; 28
Di Rosa (10.1016/j.mgene.2020.100686_bb0015) 2016; 83
Zheng (10.1016/j.mgene.2020.100686_bb0170) 2011; 54
Edge (10.1016/j.mgene.2020.100686_bb0020) 2010
Oken (10.1016/j.mgene.2020.100686_bb0115) 1982; 5
Pelloski (10.1016/j.mgene.2020.100686_bb0125) 2005; 11
Shaker (10.1016/j.mgene.2020.100686_bb0150) 2016
Johansen (10.1016/j.mgene.2020.100686_bb0065) 2006; 53
Recklies (10.1016/j.mgene.2020.100686_bb0140) 2002; 365
References_xml – volume: 66
  start-page: 503
  year: 2006
  end-page: 513
  ident: bb0010
  article-title: Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma
  publication-title: Prostate
  contributor:
    fullname: Iversen
– volume: 3
  start-page: 732
  year: 2015
  end-page: 736
  ident: bb0060
  article-title: Hepatocellular carcinoma: risk factors, diagnosis and treatment
  publication-title: Maced. J. Med. Sci.
  contributor:
    fullname: Janevski
– volume: 10
  start-page: 742
  year: 2011
  end-page: 751
  ident: bb0040
  article-title: A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers
  publication-title: Mol. Cancer Ther.
  contributor:
    fullname: Shao
– volume: 32
  start-page: 665
  year: 2012
  end-page: 674
  ident: bb0045
  article-title: YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C
  publication-title: Liver Int.
  contributor:
    fullname: Group
– volume: 6
  start-page: 35282
  year: 2016
  ident: bb0080
  article-title: Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease
  publication-title: Sci. Rep.
  contributor:
    fullname: Kanto
– volume: 278
  start-page: 44058
  year: 2003
  end-page: 44067
  ident: bb0145
  article-title: Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Krause
– volume: 57
  start-page: 99
  year: 2013
  end-page: 105
  ident: bb0100
  article-title: CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors
  publication-title: Immunol. Res.
  contributor:
    fullname: Iragavarapu-Charyulu
– volume: 4
  year: 2009
  ident: bb0135
  article-title: Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits
  publication-title: PLoS One
  contributor:
    fullname: Vestergaard
– volume: 365
  start-page: 119
  year: 2002
  end-page: 126
  ident: bb0140
  article-title: The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways
  publication-title: Biochem. J.
  contributor:
    fullname: Ling
– volume: 101
  start-page: 1563
  year: 2007
  end-page: 1571
  ident: bb0075
  article-title: A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker
  publication-title: Respir. Med.
  contributor:
    fullname: van den Bosch
– volume: 355
  start-page: 983
  year: 2006
  end-page: 991
  ident: bb0120
  article-title: DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: Soria
– volume: 14
  start-page: 136
  year: 2017
  end-page: 142
  ident: bb0055
  article-title: Correlation of chitinase 3-like 1 single nucleotide polymorphisms with hepatocellular carcinoma in Taiwan
  publication-title: Int. J. Med. Sci.
  contributor:
    fullname: Liu
– volume: 287
  start-page: 79
  year: 2003
  end-page: 87
  ident: bb0110
  article-title: gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells
  publication-title: Exp. Cell Res.
  contributor:
    fullname: Millis
– year: 2010
  ident: bb0020
  article-title: The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM
  publication-title: Ann. Surg. Oncol.
  contributor:
    fullname: Compton
– volume: 11
  start-page: 3326
  year: 2005
  end-page: 3334
  ident: bb0125
  article-title: YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Aldape
– volume: 8
  start-page: 1
  year: 2018
  end-page: 12
  ident: bb0130
  article-title: CHI3L1 promotes tumor progression by activating TGF-β signaling pathway in hepatocellular carcinoma
  publication-title: Sci. Rep.
  contributor:
    fullname: Lin
– volume: 54
  start-page: 51
  year: 2011
  end-page: 55
  ident: bb0170
  article-title: Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population
  publication-title: Cytokine
  contributor:
    fullname: Shen
– volume: 80
  start-page: 12
  year: 2007
  end-page: 18
  ident: bb0165
  article-title: Functional variants in the promoter region of chitinase 3–like 1 (CHI3L1) and susceptibility to schizophrenia
  publication-title: Am. J. Hum. Genet.
  contributor:
    fullname: He
– volume: 19
  start-page: 817
  year: 2012
  end-page: 825
  ident: bb0175
  article-title: Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery
  publication-title: Ann. Surg. Oncol.
  contributor:
    fullname: Ma
– volume: 27
  start-page: 572
  year: 2009
  end-page: 578
  ident: bb0070
  article-title: Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population
  publication-title: J. Clin. Oncol.
  contributor:
    fullname: Nordestgaard
– volume: 15
  start-page: 5249
  year: 2009
  end-page: 5259
  ident: bb0035
  article-title: Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells
  publication-title: World J. Gastroenterol.
  contributor:
    fullname: Mizoguchi
– volume: 28
  start-page: 4456
  year: 2009
  end-page: 4468
  ident: bb0155
  article-title: YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
  publication-title: Oncogene
  contributor:
    fullname: Yan
– start-page: 3
  year: 2016
  end-page: 4
  ident: bb0150
  article-title: Epidemiology of HCC in Egypt
  publication-title: Gastroenterol. Hepatol.
  contributor:
    fullname: Shaker
– volume: 32
  start-page: 133
  year: 2012
  end-page: 138
  ident: bb0005
  article-title: Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance
  publication-title: Neuropathology
  contributor:
    fullname: Giangaspero
– volume: 83
  start-page: 228
  year: 2016
  end-page: 242
  ident: bb0015
  article-title: Chitinase 3 Like-1: an emerging molecule involved in diabetes and diabetic complications
  publication-title: Pathobiology
  contributor:
    fullname: Malaguarnera
– volume: 43
  start-page: 1195
  year: 2010
  end-page: 1200
  ident: bb0090
  article-title: A promoter polymorphism −2122C>T of CHI3L1 is associated with serum low density lipoprotein cholesterol level in Korean subjects
  publication-title: Clin. Biochem.
  contributor:
    fullname: Yoon
– volume: 5
  start-page: 649
  year: 1982
  end-page: 655
  ident: bb0115
  article-title: Toxicity and response criteria of the eastern cooperative oncology group, Robert Comis M.D., group chair
  publication-title: Am. J. Clin. Oncol.
  contributor:
    fullname: Carbone
– volume: 206
  start-page: 1149
  year: 2009
  end-page: 1166
  ident: bb0085
  article-title: Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis
  publication-title: J. Exp. Med.
  contributor:
    fullname: Elias
– volume: 64
  start-page: 9
  year: 2014
  end-page: 29
  ident: bb0160
  article-title: Cancer statistics, 2014
  publication-title: CA Cancer J. Clin.
  contributor:
    fullname: Jemal
– volume: 6
  year: 2011
  ident: bb0050
  article-title: The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease
  publication-title: PLoS One
  contributor:
    fullname: Hartl
– volume: 5
  start-page: e1082
  year: 2018
  ident: bb0105
  article-title: Liver cancer in the world : epidemiology, incidence, mortality and risk factors
  publication-title: world cancer resaerch J.
  contributor:
    fullname: Salehiniya
– volume: 98
  start-page: 931
  year: 2015
  end-page: 936
  ident: bb0095
  article-title: YKL-40/CHI3L1 drives inflammation on the road of tumor progression
  publication-title: J. Leukoc. Biol.
  contributor:
    fullname: Iragavarapu-Charyulu
– volume: 7
  year: 2012
  ident: bb0180
  article-title: Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma
  publication-title: PLoS One
  contributor:
    fullname: Gai
– volume: 400
  start-page: 207
  year: 2015
  end-page: 212
  ident: bb0030
  article-title: Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
  publication-title: Mol. Cell. Biochem.
  contributor:
    fullname: Kulac
– volume: 11
  start-page: 5193
  year: 2005
  end-page: 5198
  ident: bb0025
  article-title: Hepatocellular carcinoma in Egypt: a single center study over a decade
  publication-title: World J. Gastroenterol.
  contributor:
    fullname: Saeid
– volume: 53
  start-page: 172
  year: 2006
  end-page: 209
  ident: bb0065
  article-title: Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer
  publication-title: Dan. Med. Bull.
  contributor:
    fullname: Johansen
– volume: 287
  start-page: 79
  year: 2003
  ident: 10.1016/j.mgene.2020.100686_bb0110
  article-title: gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells
  publication-title: Exp. Cell Res.
  doi: 10.1016/S0014-4827(03)00069-7
  contributor:
    fullname: Nishikawa
– volume: 10
  start-page: 742
  year: 2011
  ident: 10.1016/j.mgene.2020.100686_bb0040
  article-title: A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-10-0868
  contributor:
    fullname: Faibish
– volume: 400
  start-page: 207
  year: 2015
  ident: 10.1016/j.mgene.2020.100686_bb0030
  article-title: Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-014-2277-y
  contributor:
    fullname: Erfan
– volume: 5
  start-page: e1082
  year: 2018
  ident: 10.1016/j.mgene.2020.100686_bb0105
  article-title: Liver cancer in the world : epidemiology, incidence, mortality and risk factors
  publication-title: world cancer resaerch J.
  contributor:
    fullname: Mohammadian
– start-page: 3
  year: 2016
  ident: 10.1016/j.mgene.2020.100686_bb0150
  article-title: Epidemiology of HCC in Egypt
  publication-title: Gastroenterol. Hepatol.
  contributor:
    fullname: Shaker
– volume: 98
  start-page: 931
  year: 2015
  ident: 10.1016/j.mgene.2020.100686_bb0095
  article-title: YKL-40/CHI3L1 drives inflammation on the road of tumor progression
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.3VMR0415-142R
  contributor:
    fullname: Libreros
– volume: 4
  year: 2009
  ident: 10.1016/j.mgene.2020.100686_bb0135
  article-title: Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0005469
  contributor:
    fullname: Rathcke
– volume: 206
  start-page: 1149
  year: 2009
  ident: 10.1016/j.mgene.2020.100686_bb0085
  article-title: Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20081271
  contributor:
    fullname: Lee
– volume: 80
  start-page: 12
  year: 2007
  ident: 10.1016/j.mgene.2020.100686_bb0165
  article-title: Functional variants in the promoter region of chitinase 3–like 1 (CHI3L1) and susceptibility to schizophrenia
  publication-title: Am. J. Hum. Genet.
  doi: 10.1086/510438
  contributor:
    fullname: Zhao
– volume: 7
  year: 2012
  ident: 10.1016/j.mgene.2020.100686_bb0180
  article-title: Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma
  publication-title: PLoS One
  contributor:
    fullname: Zhu
– volume: 32
  start-page: 133
  year: 2012
  ident: 10.1016/j.mgene.2020.100686_bb0005
  article-title: Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance
  publication-title: Neuropathology
  doi: 10.1111/j.1440-1789.2011.01252.x
  contributor:
    fullname: Antonelli
– volume: 101
  start-page: 1563
  year: 2007
  ident: 10.1016/j.mgene.2020.100686_bb0075
  article-title: A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker
  publication-title: Respir. Med.
  doi: 10.1016/j.rmed.2006.12.006
  contributor:
    fullname: Kruit
– volume: 278
  start-page: 44058
  year: 2003
  ident: 10.1016/j.mgene.2020.100686_bb0145
  article-title: Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M306792200
  contributor:
    fullname: Rehli
– volume: 83
  start-page: 228
  year: 2016
  ident: 10.1016/j.mgene.2020.100686_bb0015
  article-title: Chitinase 3 Like-1: an emerging molecule involved in diabetes and diabetic complications
  publication-title: Pathobiology
  doi: 10.1159/000444855
  contributor:
    fullname: Di Rosa
– volume: 54
  start-page: 51
  year: 2011
  ident: 10.1016/j.mgene.2020.100686_bb0170
  article-title: Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2010.12.018
  contributor:
    fullname: Zheng
– volume: 8
  start-page: 1
  year: 2018
  ident: 10.1016/j.mgene.2020.100686_bb0130
  article-title: CHI3L1 promotes tumor progression by activating TGF-β signaling pathway in hepatocellular carcinoma
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-33239-8
  contributor:
    fullname: Qiu
– volume: 15
  start-page: 5249
  year: 2009
  ident: 10.1016/j.mgene.2020.100686_bb0035
  article-title: Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.15.5249
  contributor:
    fullname: Eurich
– volume: 6
  year: 2011
  ident: 10.1016/j.mgene.2020.100686_bb0050
  article-title: The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0024399
  contributor:
    fullname: Hector
– year: 2010
  ident: 10.1016/j.mgene.2020.100686_bb0020
  article-title: The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM
  publication-title: Ann. Surg. Oncol.
  doi: 10.1245/s10434-010-0985-4
  contributor:
    fullname: Edge
– volume: 43
  start-page: 1195
  year: 2010
  ident: 10.1016/j.mgene.2020.100686_bb0090
  article-title: A promoter polymorphism −2122C>T of CHI3L1 is associated with serum low density lipoprotein cholesterol level in Korean subjects
  publication-title: Clin. Biochem.
  doi: 10.1016/j.clinbiochem.2010.07.017
  contributor:
    fullname: Lee
– volume: 365
  start-page: 119
  year: 2002
  ident: 10.1016/j.mgene.2020.100686_bb0140
  article-title: The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways
  publication-title: Biochem. J.
  doi: 10.1042/bj20020075
  contributor:
    fullname: Recklies
– volume: 57
  start-page: 99
  year: 2013
  ident: 10.1016/j.mgene.2020.100686_bb0100
  article-title: CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors
  publication-title: Immunol. Res.
  doi: 10.1007/s12026-013-8459-y
  contributor:
    fullname: Libreros
– volume: 6
  start-page: 35282
  year: 2016
  ident: 10.1016/j.mgene.2020.100686_bb0080
  article-title: Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease
  publication-title: Sci. Rep.
  doi: 10.1038/srep35282
  contributor:
    fullname: Kumagai
– volume: 27
  start-page: 572
  year: 2009
  ident: 10.1016/j.mgene.2020.100686_bb0070
  article-title: Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2008.18.8367
  contributor:
    fullname: Johansen
– volume: 355
  start-page: 983
  year: 2006
  ident: 10.1016/j.mgene.2020.100686_bb0120
  article-title: DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa060570
  contributor:
    fullname: Olaussen
– volume: 19
  start-page: 817
  year: 2012
  ident: 10.1016/j.mgene.2020.100686_bb0175
  article-title: Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery
  publication-title: Ann. Surg. Oncol.
  doi: 10.1245/s10434-011-2026-3
  contributor:
    fullname: Zhu
– volume: 11
  start-page: 5193
  year: 2005
  ident: 10.1016/j.mgene.2020.100686_bb0025
  article-title: Hepatocellular carcinoma in Egypt: a single center study over a decade
  publication-title: World J. Gastroenterol.
  contributor:
    fullname: El-Zayadi
– volume: 14
  start-page: 136
  year: 2017
  ident: 10.1016/j.mgene.2020.100686_bb0055
  article-title: Correlation of chitinase 3-like 1 single nucleotide polymorphisms with hepatocellular carcinoma in Taiwan
  publication-title: Int. J. Med. Sci.
  doi: 10.7150/ijms.17754
  contributor:
    fullname: Huang
– volume: 32
  start-page: 665
  year: 2012
  ident: 10.1016/j.mgene.2020.100686_bb0045
  article-title: YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C
  publication-title: Liver Int.
  doi: 10.1111/j.1478-3231.2011.02686.x
  contributor:
    fullname: Fontana
– volume: 28
  start-page: 4456
  year: 2009
  ident: 10.1016/j.mgene.2020.100686_bb0155
  article-title: YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
  publication-title: Oncogene
  doi: 10.1038/onc.2009.292
  contributor:
    fullname: Shao
– volume: 66
  start-page: 503
  year: 2006
  ident: 10.1016/j.mgene.2020.100686_bb0010
  article-title: Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma
  publication-title: Prostate
  doi: 10.1002/pros.20311
  contributor:
    fullname: Brasso
– volume: 5
  start-page: 649
  year: 1982
  ident: 10.1016/j.mgene.2020.100686_bb0115
  article-title: Toxicity and response criteria of the eastern cooperative oncology group, Robert Comis M.D., group chair
  publication-title: Am. J. Clin. Oncol.
  doi: 10.1097/00000421-198212000-00014
  contributor:
    fullname: Oken
– volume: 3
  start-page: 732
  year: 2015
  ident: 10.1016/j.mgene.2020.100686_bb0060
  article-title: Hepatocellular carcinoma: risk factors, diagnosis and treatment
  publication-title: Maced. J. Med. Sci.
  doi: 10.3889/oamjms.2015.111
  contributor:
    fullname: Janevska
– volume: 53
  start-page: 172
  year: 2006
  ident: 10.1016/j.mgene.2020.100686_bb0065
  article-title: Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer
  publication-title: Dan. Med. Bull.
  contributor:
    fullname: Johansen
– volume: 64
  start-page: 9
  year: 2014
  ident: 10.1016/j.mgene.2020.100686_bb0160
  article-title: Cancer statistics, 2014
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21208
  contributor:
    fullname: Siegel
– volume: 11
  start-page: 3326
  year: 2005
  ident: 10.1016/j.mgene.2020.100686_bb0125
  article-title: YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-04-1765
  contributor:
    fullname: Pelloski
SSID ssj0001219516
Score 1.8272405
Snippet The chitinase 3-like 1 (CHI3L1) gene encodes the YKL-40 protein. Serum YKL-40 levels are controlled by polymorphisms in the CHI3L1 gene. We aimed to examine...
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 100686
SubjectTerms Chitinase 3-like 1
HCC
Polymorphism
YKL-40
Title Chitinase 3-like 1 gene (T/C) polymorphism and serum YKL-40 levels in patients with hepatocellular carcinoma
URI https://dx.doi.org/10.1016/j.mgene.2020.100686
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF5KRfAiPvFZ9uBBwdAkm2zTYy2WaqUHbbGewmYfNNqmxaYH_70zmwQqiAdPIY8ly7ebmdnNN98QcsUkBB2s5Tq-p1wnYEo6IhKYwMwiGTIphLYs3yHvj4PHSTipkW6VC4O0ytL2FzbdWuvySrNEs7lM0-aLjyLbgf2VhqpRqAnKQs8m8U3uNvZZPAgibI05eB55AG4lPmRpXnMYJ5TL9C1hgGNO9W8OasPp9PbIbhkt0k7RoX1S09kB2S7qR34dkll3muZpBo6IMmeWfmjqUXwRvR41uzd0uZjByh6ATFdzKjJFYbqt5_Rt8ATrOTpDutCKphkttVVXFDdl6RQcVL7ADX1kqFKJxYayxVwckXHvftTtO2X5BEeCX8qdBHy1awKpcMkSKh4FbSXaRrCWNoYnBm4aJkzbGFcJ7osAPkfdZiwUvtFuErJjUs8WmT4h1HANcaNRvmZhAM1FEjHDhYy4J4Qr1Sm5rTCLl4VKRlzRx95jC3GMEMcFxKeEV7jGPwY7Bjv-V8Oz_zY8Jzt4VnC8Lkg9_1zrS4gm8qRBtjoPg_4Qj4Pn10HDTp9v6hTKZQ
link.rule.ids 315,783,787,3513,24128,27936,27937,45691,45886
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF5qRfQiPrE-9-BBwdA0m2yTowaltbUXW6insNkHjbZpsenBf-9MHlBBPHjNMiR8OzuPzTczhFwzCUEHa9uW01K25TIlLeELLGBmvvSYFELnLN8B74zc57E3rpGwqoVBWmVp-wubnlvr8kmzRLO5SJLmq4NNtt38Vxp2jXI3yCaWXaKad8cPaxctLYgi8iFzIIBEALvqPpTzvGawUdgv08kZAxyLqn_zUGte52mP7JbhIr0vvmif1HR6QLaKAZJfh2QaTpIsScETUWZNkw9NWxRfRG-GzfCWLuZTSO0ByWQ5oyJVFPRtNaNvvT4kdHSKfKElTVJaNlddUryVpRPwUNkcb_SRokolThtK5zNxREZPj8OwY5XzEywJjimzYnDWtnGlwpzFU9x3AyUCI1hbG8NjA4uGCRMYYyvBHeHCedQBY55wjLZjjx2TejpP9QmhhmsIHI1yNPNcEBexzwwX0uctIWypGuSuwixaFG0yooo_9h7lEEcIcVRA3CC8wjX6sdsRGPK_BE__K3hFtjvDl37U7w56Z2QHVwrC1zmpZ58rfQGhRRZf5qrzDZEdymI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chitinase+3-like+1+gene+%28T%2FC%29+polymorphism+and+serum+YKL-40+levels+in+patients+with+hepatocellular+carcinoma&rft.jtitle=Meta+Gene&rft.au=Saleh%2C+Amany+A.&rft.au=Alhanafy%2C+Alshimaa+M.&rft.au=Elbahr%2C+Osama&rft.au=El-Hefnawy%2C+Sally+M.&rft.date=2020-06-01&rft.pub=Elsevier+B.V&rft.issn=2214-5400&rft.eissn=2214-5400&rft.volume=24&rft_id=info:doi/10.1016%2Fj.mgene.2020.100686&rft.externalDocID=S2214540020300414
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2214-5400&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2214-5400&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2214-5400&client=summon